| CAS No. | 1110813-31-4 |
|---|---|
| MDL No. | MFCD19443734 |
| MF | C24H25ClFN5O2 |
| MW | 469.90 |
| InChI Key | LVXJQMNHJWSHET-AATRIKPKSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Dacomitinib is a 7-methoxyquinazoline-4,6-diamine with the 4-amino group substituted by a 3-chloro-4-fluorophenyl group and the 6-amino group substituted by an (E)-4-(piperidin-1-yl)but-2-enoyl group. It functions as an epidermal growth factor receptor antagonist and antineoplastic agent. It belongs to the classes of quinazolines, piperidines, enamides, monochlorobenzenes, monofluorobenzenes, tertiary amino compounds, secondary amino compounds, and secondary carboxamides.
| CAS No. | 1110813-31-4 |
|---|---|
| Product Name | Dacomitinib |
